×
Close
Sign Up
Login
Home
People
Photos
Videos
Topics
Bookmarks
Who viewed me
Events
Services
MDLA Events Platform
MDLA Events
MDLA Events Services & Pricing
Media Services & Pricing
User Tools
FAQ
Questions
User Notes
Feedback
Advertise with Us
Languages
English
中文
French
Português
Español
Arabic
Russian
About Us
Contact Us
×
Close
Search Filters
list
All Results
person
Activities
Search Results "#alopeciaareata"
Activities
View More Results
Mary Grace N. Tamio (Gra Sya)
on October 09 2023 at 09:14 PM
Edited
public
Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
#dupilumabtherapy
#alopeciaareata
#journals
#articles
More info | ⬇️
https://social.cn1699.cn/livenewss/news/966517/Case-report-Dupilumab-therapy-for-alopecia-areata-in-a-4-year-old-patient-resistant-to-baricitinib
Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib | CN1699 Social
The social Community for Global Healthcare Elites. Doctors, Medical Professionals & Pharmaceutical professionals. Medical Thesis Abstracts and...
0
0
0
0
0
0
0
comment
Comment
thumb_up
Like
share
Share
Mary Grace N. Tamio (Gra Sya)
on August 22 2023 at 05:43 PM
Edited
public
Alopecia Areata: Current Treatments and New Directions
#alopeciaareata
#hairloss
#journals
#articles
More info | ⬇️
https://social.cn1699.cn/livenewss/news/934841/Alopecia-Areata-Current-Treatments-and-New-Directions
Alopecia Areata: Current Treatments and New Directions | CN1699 Social
The social Community for Global Healthcare Elites. Doctors, Medical Professionals & Pharmaceutical professionals. Medical Thesis Abstracts and...
0
0
0
0
0
0
0
comment
Comment
thumb_up
Like
share
Share
Mary Grace N. Tamio
on April 18 2023 at 10:41 PM
Edited
public
Progress in search for alopecia areata treatment for adolescents
#alopecoa
#alopeciaareata
More info | ⬇️
https://cn1699.com/news/progress-search-alopecia-areata-treatment-adolescents
Progress in search for alopecia areata treatment for adolescents | CN1699
The new oral medication studied in the clinical trial, a Janus kinase (JAK) inhibitor known as ritlecitinib, was developed by Pfizer. Other JAK...
0
0
0
0
0
0
0
comment
Comment
thumb_up
Like
share
Share
Modal title
×
Modal title
×
Share
Login
Global News and Health Forum
Join Now!
Member Login
Remember me
Forgot password?